{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:03:27Z","timestamp":1789599807083,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Med."],"abstract":"<jats:p>Human papillomavirus (HPV), a member of the Papillomaviridae family, infects a broad range of animal hosts and is responsible for the majority of cervical cancers and a substantial proportion of oropharyngeal cancers. Current treatment strategies for HPV-associated cervical disease depend largely on disease stage, with preinvasive and early invasive lesions commonly managed through surgical excision or radiation. Additionally, more advanced cases often require chemotherapy, immunotherapy, or combination regimens. Prophylactic vaccination remains the most effective preventive approach, and currently available vaccines, including Gardasil, Gardasil-9, and Cervarix, rely on L1-based virus-like particles (VLPs) to induce protective immunity. At the same time, increasing interest has emerged in the use of nanomaterials and viral capsids as platforms for targeted drug and gene delivery, alongside the development of higher-throughput methods for nanoparticle and viral characterization. Modified HPV capsids have shown promise for cell-specific targeting and more efficient cargo delivery with reduced off-target cytotoxicity. In this study, the HPV16 structural proteins L1 and L2 were fused to the N- and C-terminal halves of the Venus fluorophore, respectively, using a specially designed linker intended to preserve capsid assembly while reducing VLP aggregation associated with current production methods. The resulting bimolecular fluorescence complementation (BiFC)-based VLPs demonstrated reduced aggregation and improved total particle yield. In addition, the particles generated a detectable YFP signal, supporting fluorescence-based monitoring of VLP assembly and providing a potential basis for high-throughput particle characterization and sorting. This intrinsic fluorescent signal may also reduce reliance on separately packaged reporter constructs for downstream analysis.<\/jats:p>","DOI":"10.3389\/fmmed.2026.1941186","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:10:25Z","timestamp":1789596625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel approach to HPV16 VLP construction and production with improved accessibility and particle sorting potential"],"prefix":"10.3389","volume":"6","author":[{"given":"Morgan","family":"Williamson","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Texas Tech University","place":["Lubbock, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Boren","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Texas Tech University","place":["Lubbock, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Texas Tech University","place":["Lubbock, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Gollahon","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Texas Tech University","place":["Lubbock, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1080\/02786826.2015.1077927","article-title":"Evaluation of DMA size selection of dry dispersed mineral dust particles","volume":"49","author":"Ardon-Dryer","year":"2015","journal-title":"Aerosol Sci. Technol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11051-020-04840-8","article-title":"Nanoparticle number concentration measurements by multi-angle dynamic light scattering","volume":"22","author":"Austin","year":"2020","journal-title":"J. Nanoparticle Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/e23020181","article-title":"Survival of virus particles in water droplets: hydrophobic forces and landauer's principle","volume":"23","author":"Bormashenko","year":"2021","journal-title":"Entropy (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1128\/jvi.78.2.751-757.2004","article-title":"Efficient intracellular assembly of papillomaviral vectors","volume":"78","author":"Buck","year":"2004","journal-title":"J. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/JVI.79.5.2839-2846.2005","article-title":"Maturation of papillomavirus capsids","volume":"79","author":"Buck","year":"2005","journal-title":"J. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1371\/journal.ppat.0020069","article-title":"Carrageenan is a potent inhibitor of papillomavirus infection","volume":"2","author":"Buck","year":"2006","journal-title":"PLoS Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.virol.2013.05.038","article-title":"The papillomavirus major capsid protein L1","volume":"445","author":"Buck","year":"2013","journal-title":"Virology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e01104","DOI":"10.1128\/mBio.01104-14","article-title":"Maturation of the human papillomavirus 16 capsid","volume":"5","author":"Cardone","year":"2014","journal-title":"mBio"},{"key":"B9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/v11070596","article-title":"Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias?","volume":"11","author":"Cagno","year":"2019","journal-title":"Viruses"},{"key":"B10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.omtm.2017.04.005","article-title":"Efficient production of papillomavirus gene delivery vectors in defined in vitro reactions","volume":"5","author":"Cerqueira","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1128\/JVI.02497-15","article-title":"A cell-free assembly system for generating infectious human papillomavirus 16 capsids implicates a size discrimination mechanism for preferential viral genome packaging","volume":"90","author":"Cerqueira","year":"2016","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/s1097-2765(00)80449-9","article-title":"Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16","volume":"5","author":"Chen","year":"2000","journal-title":"Mol. Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1089\/hum.2023.032","article-title":"Assessment of residual full-length SV40 large T antigen in clinical-grade adeno-associated virus vectors produced in 293T cells","volume":"34","author":"De","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/v14102308","article-title":"Revisiting papillomavirus taxonomy: a proposal for updating the current classification in line with evolutionary evidence","volume":"14","author":"Van Doorslaer","year":"2022","journal-title":"Viruses"},{"key":"B16","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/AEM.71.2.912-920.2005","article-title":"Adhesion-aggregation and inactivation of poliovirus 1 in groundwater stored in a hydrophobic container","volume":"71","author":"Gassilloud","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1021\/acsomega.3c00738","article-title":"Synthesis and evaluation of BSA-loaded PLGA-chitosan composite nanoparticles for the protein-based drug delivery system","volume":"8","author":"Gaur","year":"2023","journal-title":"ACS Omega"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.3390\/molecules28176201","article-title":"Field-flow fractionation in molecular biology and biotechnology","volume":"28","author":"Giordani","year":"2023","journal-title":"Molecules"},{"key":"B19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.str.2016.12.001","article-title":"Cryoelectron microscopy maps of human papillomavirus 16 reveal L2 densities and heparin binding site","volume":"25","author":"Guan","year":"2017","journal-title":"Structure"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.1038\/s41467-025-64181-9","article-title":"Engineering a streamlined virus-like particle for programmable tissue-specific gene delivery","volume":"16","author":"Han","year":"2025","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"110946","DOI":"10.1016\/j.jbc.2025.110946","article-title":"Scalable purification enables high-quality virus-like particles for therapeutic translation","volume":"301","author":"Ho\u0142ubowicz","year":"2025","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00262-023-03425-3","article-title":"Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors","volume":"72","author":"Huis In 't Veld","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12896-016-0296-3","article-title":"Characterization of human papillomavirus type 16 pseudovirus containing histones","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Biotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/v14081656","article-title":"Harnessing human papillomavirus' natural tropism to target tumors","volume":"14","author":"Kines","year":"2022","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ijc.29823","article-title":"Human papillomavirus capsids preferentially bind and infect tumor cells","volume":"138","author":"Kines","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1158\/2326-6066.CIR-19-0974","article-title":"Virus-like particle-drug conjugates induce protective, long-lasting adaptive antitumor immunity in the absence of specifically targeted tumor antigens","volume":"9","author":"Kines","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/biomedicines10082024","article-title":"Tumor temperature: friend or foe of virus-based cancer immunotherapy","volume":"10","author":"Knapp","year":"2022","journal-title":"Biomedicines"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.55003\/cast.2025.265704","article-title":"Optimizing primary isolation of recombinant HPV L1 protein type 58 from Hansenula polymorpha","volume":"26","author":"Kopitak","year":"2025","journal-title":"Curr. Appl. Sci. Technol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.xphs.2018.12.017","article-title":"Application of a best practice approach using resonant mass measurement for biotherapeutic product characterization","volume":"108","author":"Krueger","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12985-022-01826-x","article-title":"Anti-L1 antibody-bound HPV16 pseudovirus is degraded intracellularly via TRIM21\/proteasomal pathway","volume":"19","author":"Li","year":"2022","journal-title":"Virol. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/bioinformatics\/btt473","article-title":"lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests","volume":"29","author":"Mariani","year":"2013","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/vaccines10010049","article-title":"Biophysical characterization of viral and lipid-based vectors for vaccines and therapeutics with light scattering and calorimetric techniques","volume":"10","author":"Markova","year":"2022","journal-title":"Vaccines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/pathogens14090880","article-title":"Global burden and incidence trends in cancers associated with human papillomavirus infection: a population-based systematic study","volume":"14","author":"Meng","year":"2025","journal-title":"Pathogens"},{"key":"B35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.3390\/ijms25147616","article-title":"HPV infections\u2014classification, pathogenesis, and potential new therapies","volume":"25","author":"Mlynarczyk-Bonikowska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human papillomavirus and cervical cancer","volume":"40","author":"Okunade","year":"2020","journal-title":"J. Obstet. Gynaecol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/v14020438","article-title":"Viral aggregation: the knowns and unknowns","volume":"14","author":"Pradhan","year":"2022","journal-title":"Viruses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1002\/bies.70091","article-title":"Flow cytometry: advances, challenges and trends","volume":"48","author":"Robinson","year":"2026","journal-title":"Bioessays"},{"key":"B40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2174\/0929866525666180809124633","article-title":"VLP production from recombinant L1\/L2 HPV-16 protein expressed in Pichia pastoris","volume":"25","author":"Sanchooli","year":"2018","journal-title":"Protein Pept. Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virusres.2016.11.020","article-title":"Developments in L2-based human papillomavirus (HPV) vaccines","volume":"231","author":"Schellenbacher","year":"2017","journal-title":"Virus Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/s41598-018-20877-1","article-title":"Archimedes' principle for characterisation of recombinant whole cell biocatalysts","volume":"8","author":"Schmitt","year":"2018","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1006\/mthe.2000.0212","article-title":"Multiplicity of infection\/multiplicity of confusion","volume":"2","author":"Shabram","year":"2000","journal-title":"Mol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2144\/000112036","article-title":"Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions","volume":"40","author":"Shyu","year":"2006","journal-title":"Biotechniques"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.vaccine.2006.11.049","article-title":"A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11","volume":"25","author":"Slupetzky","year":"2007","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/v16050802","article-title":"Analysis of individual viral particles by flow virometry","volume":"16","author":"Tabler","year":"2024","journal-title":"Viruses"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e00285\u201326","DOI":"10.1128\/jvi.00285-26","article-title":"Regulation of HPV-16 infection by ubiquitination of the L1 major capsid protein","author":"Trejo-Cerro","year":"2026","journal-title":"J. Virology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/s41467-020-16639-1","article-title":"Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S1473-3099(22)00435-2","article-title":"Efficacy, safety, and immunogenicity of an escherichia coli-produced human papillomavirus (16 and 18) L1 virus-like-particle vaccine: End-Of-Study analysis of a phase 3, double-blind, randomised, controlled trial","volume":"12","author":"Zhao","year":"2022","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Molecular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2026.1941186\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:10:26Z","timestamp":1789596626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2026.1941186\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":50,"alternative-id":["10.3389\/fmmed.2026.1941186"],"URL":"https:\/\/doi.org\/10.3389\/fmmed.2026.1941186","relation":{},"ISSN":["2674-0095"],"issn-type":[{"value":"2674-0095","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1941186"}}